Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

TLC

Taiwan Liposome (TLC)

Taiwan Liposome Company Ltd
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:TLC
日付受信時刻ニュースソース見出しコード企業名
2023/11/2017 : 54GlobeNewswire Inc.Highlights of Dr. David Hunter’s Oral Presentation at ACR’s Late Breaking Abstracts SessionNASDAQ:TLCTaiwan Liposome Company Ltd
2023/11/0818 : 54GlobeNewswire Inc.TLC to Present Phase 3 Data of TLC599 in Late-Breaking Abstracts Session at ACRNASDAQ:TLCTaiwan Liposome Company Ltd
2022/06/1319 : 30GlobeNewswire Inc.TLC Announces TLC599 Agreement with EndoNASDAQ:TLCTaiwan Liposome Company Ltd
2022/03/0718 : 57GlobeNewswire Inc.TLC BioSciences Announces Publication of TLC599 Phase II Results in Arthritis Research & TherapyNASDAQ:TLCTaiwan Liposome Company Ltd
2022/02/1906 : 04Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TLCTaiwan Liposome Company Ltd
2022/01/2720 : 13Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/10/2105 : 09Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/10/1519 : 33Edgar (US Regulatory)Amended Tender Offer/rights Offering Notification (cb/a)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/09/1605 : 02Edgar (US Regulatory)Amended Tender Offer/rights Offering Notification (cb/a)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/09/1600 : 57Edgar (US Regulatory)Appointment of Agent for Service of Process and Undertaking (f-x)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/09/0905 : 11Edgar (US Regulatory)Amended Tender Offer/rights Offering Notification (cb/a)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/09/0817 : 40GlobeNewswire Inc.TLC Announces Voluntary Delisting and Deregistration of American Depositary SharesNASDAQ:TLCTaiwan Liposome Company Ltd
2021/08/2705 : 11Edgar (US Regulatory)Amended Tender Offer/rights Offering Notification (cb/a)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/08/2705 : 02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/08/2505 : 02Edgar (US Regulatory)Amended Tender Offer/rights Offering Notification (cb/a)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/08/2105 : 08Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/08/1218 : 44GlobeNewswire Inc.TLC Reports Second Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:TLCTaiwan Liposome Company Ltd
2021/08/0701 : 51Edgar (US Regulatory)Amended Tender Offer/rights Offering Notification (cb/a)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/08/0603 : 38Edgar (US Regulatory)Tender Offer/rights Offering Notification (cb)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/08/0422 : 14Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/07/2219 : 05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/07/0806 : 19Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/07/0619 : 44Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/07/0519 : 16GlobeNewswire Inc.TLC Announces Details of Stock Swap TransactionsNASDAQ:TLCTaiwan Liposome Company Ltd
2021/05/2617 : 30GlobeNewswire Inc.TLC and Zydus Enter Agreement to Launch AmphoTLC™ in IndiaNASDAQ:TLCTaiwan Liposome Company Ltd
2021/05/2518 : 05GlobeNewswire Inc.TLC Announces Approval of New Drug Application of Liposomal Amphotericin B in IndiaNASDAQ:TLCTaiwan Liposome Company Ltd
2021/05/2322 : 00GlobeNewswire Inc.InspirMed Highlights Encouraging Data on ISPM21 and ISPM19 – Inhalable Liposome Formulations of Antiviral Drugs for COVID-1...NASDAQ:TLCTaiwan Liposome Company Ltd
2021/05/1420 : 32GlobeNewswire Inc.TLC Reports First Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:TLCTaiwan Liposome Company Ltd
2021/05/1420 : 01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/05/0318 : 15GlobeNewswire Inc.TLC Earns Highest Ranking in Corporate Governance Evaluation Seven Years RunningNASDAQ:TLCTaiwan Liposome Company Ltd
 Showing the most relevant articles for your search:NASDAQ:TLC

最近閲覧した銘柄

Delayed Upgrade Clock